HENEL ROLF H 4
4 · SCICLONE PHARMACEUTICALS INC · Filed May 18, 2009
Insider Transaction Report
Form 4
HENEL ROLF H
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2009-05-14$1.44/sh+10,000$14,400→ 207,500 totalExercise: $1.44From: 2003-05-27Exp: 2009-05-27→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2009-05-14$1.44/sh+10,000$14,400→ 60,000 total
Footnotes (1)
- [F1]Granted under the Issuer's 1995 Equity Incentive Plan.